These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 116966)

  • 1. Inhibition of human eosinophil chemotaxis by IgA paraproteins.
    Reed KJ; Van Epps DE; Williams RC
    Inflammation; 1979 Sep; 3(4):405-16. PubMed ID: 116966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of leukocyte chemotaxis by human IgA myeloma components.
    Van Epps DE; Williams RC
    J Exp Med; 1976 Nov; 144(5):1227-42. PubMed ID: 825608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins.
    Van Epps DE; Brown SL
    Infect Immun; 1981 Dec; 34(3):864-70. PubMed ID: 7333672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA paraprotein inhibition of human neutrophil chemotaxis. Reduced activity following treatment with IgA-specific protease from Neisseria gonorrhoeae.
    Van Epps DE; Plaut A; Bernier GM; Williams RC
    Inflammation; 1980 Jun; 4(2):137-44. PubMed ID: 6771212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of polymorphonuclear-neutrophil derived eosinophil chemotactic factor by human serum.
    König W; Czarnetzki BM
    Int Arch Allergy Appl Immunol; 1978; 57(5):399-410. PubMed ID: 352966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human PMN bactericidal activity by human IgA paraproteins.
    Van Epps DE; Reed K; Williams RC
    Cell Immunol; 1978 Mar; 36(2):363-76. PubMed ID: 343924
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of leucocyte chemokinesis and chemotaxis by human IgA.
    Kemp AS; Cripps AW; Brown S
    Clin Exp Immunol; 1980 May; 40(2):388-95. PubMed ID: 7438544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effect of IgA soluble immune complexes on neutrophil chemotaxis.
    Ito S; Mikawa H; Shinomiya K; Yoshida T
    Clin Exp Immunol; 1979 Sep; 37(3):436-40. PubMed ID: 116785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils.
    Walsh GM; Kay AB
    Clin Exp Immunol; 1986 Feb; 63(2):466-72. PubMed ID: 3698341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA-induced chemokinesis of human polymorphonuclear neutrophils: requirement of their Fc-alpha receptor.
    Sibille Y; Delacroix DL; Merill WW; Chatelain B; Vaerman JP
    Mol Immunol; 1987 Jun; 24(6):551-9. PubMed ID: 3657795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of corticosteroids on eosinophil chemotaxis and adherence.
    Altman LC; Hill JS; Hairfield WM; Mullarkey MF
    J Clin Invest; 1981 Jan; 67(1):28-36. PubMed ID: 7005265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of eosinophil leukocyte chemotaxis by a factor in normal human serum (SEF).
    Czarnetzki BM
    Int Arch Allergy Appl Immunol; 1979; 60(3):315-24. PubMed ID: 489135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
    González González JB; García Delgado R; Cámara Sáez E; Ortiz Maslloréns F
    Rev Clin Esp; 1996 Aug; 196(8):529-35. PubMed ID: 8984539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
    Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
    Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects.
    Grzegorczyk J; Majkowska-Wojciechowska B; Kowalski ML
    Mediators Inflamm; 2000; 9(1):7-13. PubMed ID: 10877449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4.
    van der Steen L; Tuk CW; Bakema JE; Kooij G; Reijerkerk A; Vidarsson G; Bouma G; Kraal G; de Vries HE; Beelen RH; van Egmond M
    Gastroenterology; 2009 Dec; 137(6):2018-29.e1-3. PubMed ID: 19555692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human neutrophil and eosinophil polymorphonuclear leukocyte chemotaxis: an analytical review.
    Valone FH
    Clin Immunol Immunopathol; 1980 Jan; 15(1):52-65. PubMed ID: 6987018
    [No Abstract]   [Full Text] [Related]  

  • 18. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited.
    Sinclair D; Smith H; Woodhead P
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):119-24. PubMed ID: 15025801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
    Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
    Goldblum SE; Van Epps DE; Reed WP
    J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.